8-K 1 eightk.txt EIGHTK.TXT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 25, 2002 GENESIS HEALTH VENTURES, INC. ---------------------------------------------------------------- (Exact name of registrant as specified in its charter)
Pennsylvania 0-33217 06-1132947 ------------ ------- ---------- (State or other jurisdiction of (Commission File Number) (IRS Employer incorporation) Identification No.)
101 East State Street, Kennett Square, Pennsylvania 19348 ---------------------------------------- ---------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (610) 444-6350 Not Applicable -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) Item 5. Other Events On November 25, 2002, Genesis Health Ventures, Inc. announced financial results for its fiscal year ended September 30, 2002. Selected Financial Data of Genesis Health Ventures, Inc. (Amounts in thousands, except per share data)
(unaudited) Twelve Months Ended September 30, 2002 ------------------- Statement of Operations Data: Net revenues........................................................ $ 2,623,679 Income from continuing operations................................... 73,794 Net income attributable to common shareholders...................... 70,167 Per common share data (diluted): Income from continuing operations .................................. 1.76 Net income attributable to common shareholders...................... $ 1.68 Weighted average shares of common stock and equivalents-- diluted.......................................................... 43,351 Other Financial Data: Capital expenditures................................................ $ 48,969 (unaudited) September 30, 2002 ------------------- Balance Sheet Data: Working capital..................................................... $ 470,310 Total assets........................................................ 1,983,977 Long-term debt...................................................... 675,770 Redeemable preferred stock.......................................... 44,765 Shareholders' equity ............................................... $ 911,601
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GENESIS HEALTH VENTURES, INC. Date: December 3, 2002 By: /s/ George V. Hager, Jr. ---------------------------------- George V. Hager, Jr. Executive Vice President and Chief Financial Officer